HomeAVXL • NASDAQ
add
Anavex Life Sciences Corp
Previous close
$4.11
Day range
$3.66 - $4.16
Year range
$2.86 - $14.44
Market cap
359.18M USD
Avg Volume
3.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.83M | -20.19% |
Net income | -9.83M | 15.43% |
Net profit margin | — | — |
Earnings per share | -0.11 | 21.43% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 102.58M | -22.40% |
Total assets | 103.82M | -23.42% |
Total liabilities | 8.95M | -41.54% |
Total equity | 94.87M | — |
Shares outstanding | 89.35M | — |
Price to book | 3.77 | — |
Return on assets | -26.26% | — |
Return on capital | -29.14% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -9.83M | 15.43% |
Cash from operations | -8.60M | -29.23% |
Cash from investing | — | — |
Cash from financing | 10.02M | 11,155.06% |
Net change in cash | 1.41M | 121.51% |
Free cash flow | -5.55M | -57.57% |
About
Founded
2004
Headquarters
Website
Employees
34
